Hydrosalpinx – Salpingostomy, salpingectomy or tubal occlusion
Hydrosalpinx – Salpingostomy, salpingectomy or tubal occlusion
Tubal factors account for approximately 25% of cases of infertility, and the most severe manifestation of tubal disease is hydrosalpinx, accounting for 10–30% of tubal diseases. Hydrosalpinx is a distension or dilatation of the fallopian tube in the presence of a distal tubal occlusion, and the most common cause is pelvic inflammatory disease. Women with hydrosalpinges have lower implantation and pregnancy rates in assisted reproductive technology (ART), due to a combination of mechanical and chemical factors thought to disrupt the endometrial environment. Current guidance is removal of the tube by salpingectomy (preferably laparoscopically) before IVF treatment. Salpingostomy, or distal tubal plastic surgery in the management of hydrosalpinx, is an alternative for women desiring natural conception, although ectopic pregnancy rates as high as 10% have been reported. Proximal tubal occlusion with Essure
®
devices placed hysteroscopically can be considered particularly in cases of distorted pelvic anatomy or pelvic adhesions making abdominal surgery complex. However, low clinical pregnancy and live birth rates have been reported with the use of these devices before IVF. In this review, we discuss salpingostomy, salpingectomy and tubal occlusion as possible management options for the reproductive women with hydrosalpinx.
Hydrosalpinx, IVF, Natural conception, Salpingectomy, Salpingostomy, Tubal occlusion
Ng, Ka Ying Bonnie
9883fa87-e225-46b5-8e71-f12d38393841
Cheong, Ying
4efbba2a-3036-4dce-82f1-8b4017952c83
Ng, Ka Ying Bonnie
9883fa87-e225-46b5-8e71-f12d38393841
Cheong, Ying
4efbba2a-3036-4dce-82f1-8b4017952c83
Ng, Ka Ying Bonnie and Cheong, Ying
(2019)
Hydrosalpinx – Salpingostomy, salpingectomy or tubal occlusion.
Best Practice and Research: Clinical Obstetrics and Gynaecology.
(doi:10.1016/j.bpobgyn.2019.01.011).
Abstract
Tubal factors account for approximately 25% of cases of infertility, and the most severe manifestation of tubal disease is hydrosalpinx, accounting for 10–30% of tubal diseases. Hydrosalpinx is a distension or dilatation of the fallopian tube in the presence of a distal tubal occlusion, and the most common cause is pelvic inflammatory disease. Women with hydrosalpinges have lower implantation and pregnancy rates in assisted reproductive technology (ART), due to a combination of mechanical and chemical factors thought to disrupt the endometrial environment. Current guidance is removal of the tube by salpingectomy (preferably laparoscopically) before IVF treatment. Salpingostomy, or distal tubal plastic surgery in the management of hydrosalpinx, is an alternative for women desiring natural conception, although ectopic pregnancy rates as high as 10% have been reported. Proximal tubal occlusion with Essure
®
devices placed hysteroscopically can be considered particularly in cases of distorted pelvic anatomy or pelvic adhesions making abdominal surgery complex. However, low clinical pregnancy and live birth rates have been reported with the use of these devices before IVF. In this review, we discuss salpingostomy, salpingectomy and tubal occlusion as possible management options for the reproductive women with hydrosalpinx.
Text
Ng Cheong Hydrosalpinx
- Accepted Manuscript
More information
Accepted/In Press date: 21 January 2019
e-pub ahead of print date: 29 January 2019
Keywords:
Hydrosalpinx, IVF, Natural conception, Salpingectomy, Salpingostomy, Tubal occlusion
Identifiers
Local EPrints ID: 429480
URI: http://eprints.soton.ac.uk/id/eprint/429480
ISSN: 1521-6934
PURE UUID: bcb1d6a0-0dcc-43ca-81cd-ae5c847cc67c
Catalogue record
Date deposited: 27 Mar 2019 17:30
Last modified: 16 Mar 2024 07:41
Export record
Altmetrics
Contributors
Author:
Ka Ying Bonnie Ng
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics